<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://ana.ir/en/news/11208/inotex-2026-innovation-and-technology-exhibition-held-in-tehran</loc><news:news><news:publication_date>2026-09-14T23:12:26+03:30</news:publication_date><news:title>INOTEX 2026 innovation and technology exhibition held in Tehran</news:title><news:publication><news:name>ana.press</news:name><news:language>en</news:language></news:publication></news:news><image:image><image:loc>https://ana.ir/media/674d771aZTp3ZWJwfGY6MTE4OTc5NS5qcGd8ZnVpOjgwODU2fGw6ZW58djox.webp</image:loc><image:title>INOTEX 2026 innovation and technology exhibition held in Tehran</image:title><image:caption>(Tehran Ana)- The 15th edition of Iran’s International Innovation and Technology Exhibition, INOTEX 2026, was held in Tehran, bringing together startups, technology companies, investors, industries, experts and innovation ecosystem stakeholders over four days.</image:caption></image:image></url><url><loc>https://ana.ir/en/news/11207/russian-tuberculosis-vaccine-enters-phase-3-trials</loc><news:news><news:publication_date>2026-09-14T22:39:48+03:30</news:publication_date><news:title>Russian tuberculosis vaccine enters Phase 3 trials</news:title><news:publication><news:name>ana.press</news:name><news:language>en</news:language></news:publication></news:news><image:image><image:loc>https://ana.ir/media/10fdb9b9ZTp3ZWJwfGY6MTE4OTY4Ni5qcGVnfGZ1aTo4MDg1NXxsOmVufHY6MQ.webp</image:loc><image:title>Russian tuberculosis vaccine enters Phase 3 trials</image:title><image:caption>(Tehran Ana)-  Russia’s Gamaleya Research Center has completed Phase 3 clinical trials of a new vaccine designed to prevent tuberculosis infection.</image:caption></image:image></url><url><loc>https://ana.ir/en/news/11206/fields-medalists-warn-of-ai-risks-to-mathematics</loc><news:news><news:publication_date>2026-09-14T22:34:30+03:30</news:publication_date><news:title>Fields Medalists warn of AI risks to mathematics</news:title><news:publication><news:name>ana.press</news:name><news:language>en</news:language></news:publication></news:news><image:image><image:loc>https://ana.ir/media/4a0a4f5dZTp3ZWJwfGY6MTE4OTY4NS5wbmd8ZnVpOjgwODU0fGw6ZW58djox.webp</image:loc><image:title>Fields Medalists warn of AI risks to mathematics</image:title><image:caption>(Tehran Ana)- Twenty-five Fields Medalists have warned that the race among AI companies to solve famous mathematical problems could cause lasting harm to the field.</image:caption></image:image></url><url><loc>https://ana.ir/en/news/11205/nanomicellar-capsule-developed-to-support-liver-health</loc><news:news><news:publication_date>2026-09-14T18:16:43+03:30</news:publication_date><news:title>Nanomicellar capsule developed to support liver health</news:title><news:publication><news:name>ana.press</news:name><news:language>en</news:language></news:publication></news:news><image:image><image:loc>https://ana.ir/media/f252cf5cZTp3ZWJwfGY6MTE4OTY3Mi5qcGd8ZnVpOjgwODUzfGw6ZW58djox.webp</image:loc><image:title>Nanomicellar capsule developed to support liver health</image:title><image:caption>(Tehran Ana)- An Iranian knowledge-based company has developed and launched an oral formulation containing nanomicellar silymarin to help prevent and manage liver diseases and damage.</image:caption></image:image></url><url><loc>https://ana.ir/en/news/11204/study-reveals-molecular-mechanism-behind-heparin-induced-thrombocytopenia</loc><news:news><news:publication_date>2026-09-14T17:33:33+03:30</news:publication_date><news:title>Study reveals molecular mechanism behind heparin-induced thrombocytopenia</news:title><news:publication><news:name>ana.press</news:name><news:language>en</news:language></news:publication></news:news><image:image><image:loc>https://ana.ir/media/4669163fZTp3ZWJwfGY6MTE4OTY1OS5qcGd8ZnVpOjgwODUyfGw6ZW58djox.webp</image:loc><image:title>Study reveals molecular mechanism behind heparin-induced thrombocytopenia</image:title><image:caption>(Tehran Ana)-  Researchers at McMaster University have identified a structural mechanism in platelet factor 4 (PF4) that may trigger the harmful immune response underlying heparin-induced thrombocytopenia (HIT).</image:caption></image:image></url></urlset>
